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Nguan CY, Guan Q, Gleave ME, Du C. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemiareperfusion injury. Am J Physiol Renal Physiol 306: F724 -F733, 2014. First published January 29, 2014; doi:10.1152/ajprenal.00410.2013.-Renal repair begins soon after the kidney suffers ischemia-reperfusion injury (IRI); however, its molecular pathways are not fully understood. Clusterin (Clu) is a chaperone protein with cytoprotective functions in renal IRI. The aim of this study was to investigate the role of Clu in renal repair after IRI. IRI was induced in the left kidneys of wild-type (WT) C57BL/6J (B6) vs. Clu knockout (KO) B6 mice by clamping the renal pedicles for 28 -45 min at the body temperature of 32°C. The renal repair was assessed by histology and confirmed by renal function. Gene expression was examined using PCR array. Here, we show that following IRI, renal tubular damage and Clu expression in WT kidneys were induced at day 1, reached the maximum at day 3, and significantly diminished at day 7 along with normal function, whereas the tubular damage in Clu KO kidneys steadily increased from initiation of insult to the end of the experiment, when renal failure occurred. Renal repair in WT kidneys was positively correlated with an increase in Ki67 ϩ proliferative tubular cells and survival from IRI. The functions of Clu in renal repair and renal tubular cell proliferation in cultures were associated with upregulation of a panel of genes that could positively regulate cell cycle progression and DNA damage repair, which might promote cell proliferation but not involve cell migration. In conclusion, these data suggest that Clu is required for renal tissue regeneration in the kidney repair phase after IRI, which is associated with promotion of tubular cell proliferation.
clusterin; kidney injury; kidney repair; cell proliferation; AKI ACUTE KIDNEY INJURY (AKI) is a common health problem that affects ϳ7-20% of hospitalized patients (35, 51) and can be caused by a variety of insults, including renal ischemia, inflammatory or infectious insults, and cytotoxic reagent or nephrotoxic drug exposure (29, 31, 51) . Typically, the kidney demonstrates a remarkable capacity to repair damage after AKI (4); however, patients with AKI have a higher risk for developing chronic kidney disease (CKD) that further leads to end-stage renal disease (ESRD) and mortality, compared with those AKI-free patients (7, 54) . The pathways by which AKI induces CKD and/or ESRD are poorly understood, but evidence in the literature suggests that it may be associated with the incomplete regeneration or repair of kidney tissues after AKI (5, 17, 31, 49) . Therefore, completely understanding renal repair or regeneration becomes critical for preventing kidney disease after AKI in patients.
Clusterin (Clu) is a glycoprotein, encoded by a single gene in both the human and mouse genomes (22) . After its translation, the presecreted or cytoplasmic form (cClu) is glycosylated in the endoplasmic reticulum and the Golgi body and is further cleaved at an internal bond between Arg-205 and Ser-206 to produce a mature protein, a heterodimer of ␣-and ␤-chains that is secreted (sClu) (10, 24) . Clu not only is a major glycoprotein in physiological fluids, such as plasma, milk, urine, cerebrospinal fluid, and semen (22) , but its expression is also upregulated in renal tissues following a variety of insults, including unilateral ureteral obstruction (UUO), ischemia-reperfusion injury (IRI) (52, 56) , transplant rejection, and intrinsic renal disease (12) . Further studies indicate that Clu is an apically secreted glycoprotein in renal tubular epithelial cells (TECs) (18) and is detected in both viable and apoptotic cells following renal injury (16, 52) . The renal cytoprotective function of Clu has been demonstrated in several animal studies. In a model of antibody-mediated glomerular injury, kidneys perfused with Clu-depleted plasma develop significantly greater proteinuria at all time points vs. control kidneys infused with normal plasma (41) . In addition, a deficiency in Clu expression worsens renal IRI (56) and in aging mice causes a progressive glomerulopathy (40) . However, the mechanisms by which Clu protects the kidney from injury, or maintains renal tissue homeostasis, are not fully understood. In the present study, the role of Clu in renal tissue repair after IRI was investigated in wild-type (WT) mice compared with Clu knockout (KO) mice.
MATERIALS AND METHODS
Animals and cell cultures. Both WT C57BL/6 (B6) and Clu KO mice in a B6 background (B6-Clu Ϫ/Ϫ ) were received from the breeding colonies in the animal facility at the Jack Bell Research Centre (Vancouver, BC). All the animals (males, 10 -12 wk old) for the experiments were cared for in accordance with the Canadian Council on Animal Care guidelines under the protocols approved by the Animal Use Subcommittee at the University of British Columbia (Vancouver, BC).
Clu null TECs were isolated from the kidney cortex of Clu KO mice as described previously (56) and were immortalized or cloned by transfection with origin-deficient SV40 DNA. The phenotype of cloned murine TECs was confirmed by their expression of E-cadherin and CD13 (alanine aminopeptidase) using fluorescence-activating cell sorting (FACS) analysis and were grown in complete K1 (K1 ϩ/ϩ ) medium as described previously (11) .
Ectopic expression of Clu in cultured TECs. Clu null TECs were converted to Clu-expressing TECs (TEC-Clu hClu ) by stable expression of human Clu isoform 1 cDNA using pHEX6300 vector, as described previously (27) , whereas Clu null TECs with stable expression of empty pHEX6300 vector were used as Clu-negative control cells (TEC-Clu Ϫ/Ϫ ). Both cell types were grown and maintained in complete K1 medium in the presence of the selective antibiotic zeocin (up to 500 g/ml) and were further selected by flow cytometric cell sorting based on the expression of pHEX6300-encoded green fluorescent protein (GFP). More than 95% of cells in both TEC-Clu hClu and TEC-Clu Ϫ/Ϫ cultures were confirmed to have a high level of GFP by either flow cytometry or fluorescence microscopy.
Renal IRI. Renal IRI was induced in the left kidney of WT vs. Clu KO mice. In brief, mice were anesthetized with a combination of ketamine (100 mg/kg) and xylazine (10 mg/kg), and isoflurane as needed. The left kidneys were exposed through a flank incision, followed by the induction of ischemia in these kidneys through clamping renal pedicles at the body temperature of 32°C for either 28 min (renal repair) or for 38 min (mouse survival). After the clamps were released, reperfusion of the kidneys was confirmed visually. In the examination of renal repair/regeneration in these left kidneys after reperfusion, the nonischemic right kidneys in the same mice were kept for life support. In the examination of renal function or mouse survival after IRI, the right kidneys were removed (unilateral nephrectomy).
Western blotting. Clu protein in protein extracts of TECs and renal tissues was examined by Western blotting as described previously (56) . Briefly, protein extract samples (100 -150 g/sample) were fractionated by 10% SDS-PAGE, then transferred onto nitrocellulose membranes. The levels of Clu protein were identified with goat polyclonal anti-Clu-␣ antibodies (1:1,000 dilution; C-18, Santa Cruz Biotechnology, Santa Cruz, CA) and visualized by an enhanced chemiluminescence assay (ECL, Amersham Pharmacia Biotech, Buckinghamshire, UK). The ␤-actin as a protein content determinant in each sample was reprobed using anti-actin IgG on the same blot (Sigma-Aldrich Canada, Oakville, ON). To quantitate the Clu expression in Western blot analysis, the density of Clu (sClu) and reprobed ␤-actin bands was measured by densitometry. In each blot, the relative level of sClu in each sample was calculated by normalization with its density of ␤-actin.
Immunohistochemical analysis. The kidneys harvested from mice were perfused with PBS before formalin fixation, paraffin embedding, and sectioning. The expression of Clu or Ki67 protein in kidney sections was assessed by a standard immunohistochemical method. Briefly, after deparaffin and rehydration buffered-formalin-fixed sections were treated with 3% H 2O2 in Tris-buffered saline (TBS; pH 7.4) for 30 min at room temperature (RT) to quench endogenous peroxidase, followed by permeabilization with 0.2% Triton X-100 for 10 min at RT. After being washed with TBS containing 0.1% Tween 20 (TBS-T) and blocked with 2% normal serum, the sections were incubated with 1:50 dilution of primary goat polyclonal anti-Clu-␣ antibody (C-18, Santa Cruz Biotechnology) or rabbit polyclonal anti-Ki67 antibodies (AB9280, EMD Millipore, Billerica, MA) overnight at 4°C. The immune complexes of Clu and anti-Clu antibody or of Ki67 and anti-Ki67 antibody on the tissue section were detected using anti-goat or anti-rabbit Ig antibody conjugated with biotin, the secondary antibody, and were visualized using a 3,3=-diaminobenzidine (DAB) peroxidase substrate kit (Vector Labs, Burlington, ON). The control negative staining included the sections incubated with normal goat or rabbit IgG instead of anti-Clu or anti-Ki67 antibody as the primary antibody.
To quantitate the expression of Clu or Ki67 in the kidney in the immunohistochemical analysis, the number of Clu-expressing tubules or Ki67-expressing cells was counted in each view, which was randomly selected in the region of renal cortex under ϫ400 magnification (high-power field; hpf). The Clu-expressing tubules or Ki67-positive cells in each kidney were quantitated by averaging at least 20 nonoverlapping fields in two serial sections.
Determination of renal function and semiquantitative assessment of renal injury. The function of the kidneys was determined using the levels of SCr or BUN. SCr was measured by using the CREA method on the Dimension Vista System with a Flex reagent cartridge in the Chemistry Laboratory at Vancouver Coastal Health Regional Laboratory Medicine (Vancouver, BC), and BUN measurement was performed using a QuantiChrom urea assay kit (BioAssay Systems).
Histological assessment of tubular injury in kidney sections was performed in a blinded fashion. Formalin-fixed and paraffin-embedded sections (5-m thickness, longitudinal) were stained by periodic acid-Schiff (PAS) methods. The percentage of damaged tubules (combined necrosis and vacuolization) in the total tubules was counted in each view, randomly selected in the region of renal cortex under ϫ400 magnification, and averaged at least of 20 nonoverlapping fields for each kidney.
PCR array. The expression of 84 cell cycle-associated genes in the kidneys or cultured TECs was quantitatively examined using PCR Array kits following the manufacturer's instructions (SABiosciencesQiagen, Valencia, CA). The kidney samples were prepared as follows: after perfusion with saline, one part of renal tissue was snap-frozen in liquid nitrogen and stored at Ϫ80°C for RNA extraction. The RNA in TECs was directly extracted from the monolayer after the removal of culture medium. In each group (Clu-expressing vs. Clu null), four different samples (renal tissue samples from 4 different animals, or TEC cultures grown at 4 different times) were randomly selected for the determination of the gene expression profile using PCR arrays. The total RNA from these samples was extracted and purified using an RNeasy Microarray Tissue Mini kit (Qiagen), and converted to cDNA using an RT 2 First Strand Kit (Qiagen). The expression of selected genes was amplified by real-time PCR using RT 2 Profile PCR arrays (Qiagen). Data were analyzed using Web-based PCR Array Data Analysis Software (www.SABiosciences.com/pcrarraydataanalysis. php).
Cell proliferation by methylthiazol tetrazolium assay. Methylthiazol tetrazolium (MTT) assay was used to measure cell proliferation or viable cell number in cultures. Cells were seeded at 2,500/well in 96-well microplates, and each condition was tested at least in quadruplicate. In brief, 10 l of 0.5 mg/ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich Canada) were added to each well and incubated at 37°C for 4 h. The formazan crystals in viable cells were then dissolved in 100 l/well of DMSO (Sigma-Aldrich Canada). The OD of the color in each well as a proliferation index was quantified at 562-nm wavelength using an ELx808 Ultra Microplate Reader (BioTek, Winooski, VT). The growth rate was calculated as follows: growth rate (OD/day) ϭ (OD end Ϫ OD begin )/time (day), where time represented the period of examination, OD end represented the absorbance unit at the end of the examination, and OD begin represented the absorbance unit at the beginning of the examination.
Cell cycle distribution analysis. TECs (1 ϫ 10 6 cells/well) were seeded in six-well plates in complete K1 medium for 24 h and arrested and synchronized cell growth in serum growth factor-free K1 medium overnight. The cells were incubated in complete K1 medium for 24 h, followed by harvesting by a brief trypsinization and centrifugation, and finally washed twice with ice-cold PBS. The staining with propidium iodide (PI; Invitrogen Canada) was performed as follows: cells were fixed with ice-cold 70% ethanol overnight, followed by treatment with 80 g/ml of DNase-free RNase and staining with 40 g/ml of PI at 37°C for 30 min. The DNA content was measured using flow cytometry or FACS and then analyzed with flowJo analysis software (Tree Star, Ashland OR).
Cell migration in a wound-healing assay. The migration of TECs (TEC-Clu hClu vs. TEC-Clu Ϫ/Ϫ ) was compared in monolayer cell cultures. Briefly, cells (1 ϫ 10 6 cells/well) were seeded in six-well plates. After overnight incubation, a wound in a cell monolayer was created by scratching with a pipette tip, followed by a gentle rinse twice with warm PBS to remove the detached cells. Cell migration at the wound edge to the wound space was captured using a Zeiss 200M Axiovert inverted microscope (Carl Zeiss Microscopy, Gottingen, Germany), and the migration distance from 0 to 6 h was calculated using Axiovison Rel 4.8 software (Carl Zeiss Microscopy).
Statistical analysis. Two-way ANOVA or t-tests (2-tailed distribution) were used as appropriate for comparisons between groups. Data were collected from individual experiments or mice in each study for statistical analysis. A P value of Յ0.05 was considered significant.
RESULTS

Clu expression is required for renal regeneration after renal IRI.
The kidney is able to repair itself after AKI by both intrinsic and extrinsic mechanisms (13), which have not yet been fully understood. To examine the impact of Clu expression on renal repair after AKI, renal function and tissue regeneration after IRI in Clu-expressing WT vs. Clu KO mice were examined.
The kinetics of both renal repair and Clu protein expression were first examined during the recovery phase of IRI. As shown in Fig. 1A , the expression of Clu protein in renal cortical tissue extracts from WT mice was upregulated following renal IRI in a time-dependent manner, reaching the highest level at day 3 postreperfusion, but declining to almost the basal levels at day 7. By immunohistochemical analysis, the expression of Clu protein was localized mainly in the renal tubules (Fig. 1B) , while an absence of Clu protein was detected in both extracts and sections of the kidneys from Clu KO mice. To reveal the correlation between renal Clu expression and tissue repair, the levels of tissue damage in the cortex of between these WT and Clu KO kidneys were semiquantitatively compared by histological analysis with PAS staining. As shown in Fig. 2 , the basal level of damaged tubules (tubules/hpf) of WT at day 0 (1.26 Ϯ 0.55) was not significantly different from that in KO controls (0.94 Ϯ 0.27), and following IRI, it was increased to 7.77 Ϯ 3.76 at day 1 in WT kidneys, and 13.62 Ϯ 7.33, a maximum level, at day 3, followed by the presence of less tubular damage (4.13 Ϯ 2.45) and tissue repair at day 7. However, in Clu KO kidneys, the tubular damage was more severe than in WT mice (P Ͻ 0.0001, WT vs. KO, 2-way ANOVA), and was not repaired at all by day 7, which was indicated by a progressive increase in tubular damage from 8.58 Ϯ 1.12 at day 1 to 22.14 Ϯ 1.7 at day 7. Taken together, these data suggest that IRI-induced Clu expression positively correlates with the levels of tubular damage in WT kidneys, and the lack of Clu expression in Clu KO kidneys impairs the renal repair or regeneration after IRI.
Renal repair deficiency in clu KO mice is associated with renal failure and mortality. To further confirm renal repair deficiency after IRI in Clu KO mice as shown in Fig. 2 , both renal function after 28 min of ischemia and mouse survival after 38 min of ischemia were examined in uninephrectomized Clu KO mice compared with WT mice. As shown in Fig. 3 , in the KO group seven of nine Clu KO mice exhibited obvious renal failure, indicated by Ͼ100 mg/dl BUN and equal to or Ͼ0.94 mg/dl SCr (6 of them: over 1 mg/dl SCr: severe renal failure), and one had mild renal failure (BUN: 101.7 mg/dl; SCr: 0.39 mg/dl). In the WT group, renal insufficiency was seen in only two of nine mice; both BUN (108.74 mg/dl) and SCr (0.63 mg/dl) in one mouse were similar to those in Clu KO mice with renal failure, and the other just had a mild degree of renal dysfunction (BUN: 101.48 mg/dl; SCr: 0.34 mg/dl). The statistical analysis indicated that the levels of both BUN and SCr in Clu KO mice were significantly higher than those in WT mice (BUN: P ϭ 0.0241; SCr: P ϭ 0.0008, n ϭ 9). When the ischemia was prolonged to 38 min in this model as shown in Fig. 4 , 7 of 10 Clu mice died in a period of 3 days after IRI, while only one died in the WT group (P ϭ 0.0048, log-rank test, n ϭ 10). Taken together, renal failure and mortality of Clu KO mice reflect the poor renal regeneration or repair after IRI in these mice.
Clu-mediated renal repair is associated with cell proliferation in tubules. To reveal the mechanisms and pathways by which Clu mediates renal repair during recovery from IRI, proliferating cells specifically labeled by the expression of nuclear protein Ki67 (42) were directly counted in the sections of WT vs. Clu KO kidneys under the microscope. As shown in Fig. 5 , the numbers of Ki67-expressing tubular cells in the WT group were changed in parallel with degree of tubular damage (Fig. 2) ; the number of proliferating cells increased from 10.65 Ϯ 3.81 at day 0 to 32.1 Ϯ 11.66 at day 3, followed by a decrease to 21.57 Ϯ 9.26 at day 7, whereas in Clu KO kidneys, the numbers of Ki67-positive cells did not significantly change following reperfusion (9.63 Ϯ 3.42 at day 0 to 14.63 Ϯ 3.88 at day 3 and 14.6 Ϯ 2.92 at day 7) and were statistically lower than those in WT kidneys (P Ͻ 0.0001, WT vs. KO, 2-way ANOVA). These data suggest that tubular damage stimulates the cell proliferation in Clu-expressing kidneys, but not in Clu null kidneys, or the lack of Clu expression disrupts cell proliferation in kidney tubules.
To further examine how Clu influences cell proliferation in the kidneys after IRI, the expression of 84 genes identified as positively or negatively regulating the cell cycle, the transitions between the phases, DNA replication, checkpoints, and arrest was examined in the kidneys after 3 days of reperfusion using a Cell Cycle PCR array. As listed in Supplemental Table S1 (all supplemental material for this article is accessible on the journal Web site), the transcription of 16 genes (Shc1, Pmp22, Skp2, Cks1b, Ccnd1, CCnd2, Mki67, Ran, Aurka, Stag1, Tsg101, Gpr132, Msh2, Hus1, Tfdp1, and Slfn1) were statistically upregulated, whereas genes Notch2 and Gadd45a were downregulated in WT kidneys compared with Clu KO kidneys used as a negative control. Among these predominantly 18 Clu-associated genes, 15 are associated with the promotion of cell cycle progression, growth, and DNA repair, while 3 (Notch2, Pmp22, Slfn1) are associated with cell cycle arrest or apoptosis.
Ectopic expression of clu enhances renal tubular cell proliferation. To further understand the functions of Clu in renal repair, the effect of ectopic expression of human Clu (hClu) on the proliferation or division and migration of TECs was examined. As shown in Fig. 6A , both cClu (presecreted or cytoplasmic form) and sClu (secreted form) were detected in Clu null TEC lines expressing the pHEX6300 vector containing full-length hClu isoform 2 cDNA, TEC-Clu hClu , while in control cells the same Clu null TEC lines that were stably expressing empty pHEX6300 (TEC-Clu Ϫ/Ϫ cells), no Clu proteins were detected.
The proliferation of TEC-Clu hClu vs. TEC-Clu Ϫ/Ϫ cells was first compared under the same normal culture conditions using an MTT assay. As shown in Fig. 6B, the absorbance (OD) values, reflecting viable cell numbers, in TEC-Clu hClu cell cultures were significantly higher than those in TEC-Clu Ϫ/Ϫ cell cultures even during the equilibrium phase at day 3 (P Ͻ 0.0001, 2-way ANOVA). Similar results were also seen when the increase in cell proliferation was calculated by the percentage following the timing of incubation until day 3 (P ϭ 0.0474, 2-way ANOVA) (Fig. 6C) . These data suggest that ectopic expression of Clu promotes cell proliferation or growth.
To further confirm this observation, cell cycle distribution in TEC-Clu hClu vs. TEC-Clu Ϫ/Ϫ cells in response to the stimulation of growth factors and serum after overnight starvation was counted using flow cytometric analysis with a PI stain. As shown in Fig. 7 and Table 1 , the cell cycle distribution of TEC-Clu hClu cells was different from that of TEC-Clu Ϫ/Ϫ cells; during a period of 24 h-incubation with growth factors and serum, the number of TEC-Clu hClu cells at the G2/M phase was significantly higher than that of TEC-Clu Ϫ/Ϫ cells, and there was a progressive shift of the cells from the G0/G1 to the S and G2/M phases of the cell cycle following the time of incubation, which was not seen in TEC-Clu Ϫ/Ϫ cells. These ϪhClu vs. TEC-Clu Ϫ/Ϫ cells was grown in complete K1 medium (containing 5% bovine serum and growth factors) after overnight starvation in serum-growth factor free K1 medium. The percentage of cells in G0/G1, S, and G2/M phases of the cell cycle in these cultured TECs was determined following the time of incubation with the complete K1 medium from 0 to 24 hrs. Data are presented as a typical graph for the cell cycle distribution in FACS analysis of each group. data suggest that ectopic expression of Clu increases the number of G2/M-arrested TECs and normalizes the cell cycle progression for cell proliferation.
Clu regulates cell cycle-related gene expression in TECs. The effect of ectopic expression of Clu on cell cycle-related genes in TECs was examined using a PCR array. As listed in Supplemental Table S1 , the expression of 52 genes was significantly affected by the presence of Clu; 50 genes were upregulated, while 2 genes (Pmp22 and Ccnd2) were downregulated. According to the functions of these genes, the effect of Clu on the cell cycle of cultured TECs was divided into three groups:
, Dst, and Tsg101) and downregulated Pmp22 promoted cell survival and cycle progression; 2) 10 upregulated genes (Gpr132, Mre11a, Msh2, Rad9, Rad17, Rad21, Atr, Brca1, Hus1, and Nbn) acted as cell cycle checkpoints in response to DNA damage; and 3) 11 upregulated genes (Casp3, Cdk5rap1, Trp53, Ppm1d, Wee1, Chek2, E2f1, E2f2, E2f3, E2f4, and Tfdp1) and downregulated gene Ccnd2 were associated with cell cycle arrest and apoptosis. Compared with the expression profile of these genes in WT kidneys against Clu KO background controls after IRI (Supplemental Table S1 ), seven genes (Shc1, Skp2, Cks1b, Ran, Aurka, Stag1, and Tsg101) for cell cycle progression and survival and three genes (Gpr132, Msh2, and Hus1) for DNA repair were commonly upregulated in both in vitro and in vivo systems, while only one gene, Tfdp1 (for stimulation of E2F-dependent transcription), in the group for cell cycle arrest and apoptosis was found to be upregulated in both systems, suggesting that Clu may have a more profound effect on the signaling pathways mediating cell cycle progression and survival rather than cell cycle arrest.
Clu suppresses TEC migration in vitro. The repair of the kidney after IRI involves both proliferation and differentiation of proximal TECs as well as cell migration (4, 36) . To understand the mechanism by which Clu mediates renal repair after IRI, the role of Clu in TEC migration was investigated. As shown in Fig. 8 , ectopic expression of Clu in TECs resulted in a decrease in cell migration in an in vitro model of wound healing, indicated by the fact that TEC-Clu ϪhClu cells migrated 105 Ϯ 17.34 m in 6 h compared with 138 Ϯ 26.9 m in TEC-Clu Ϫ/Ϫ cell cultures at the same time point (P ϭ 0.0107), suggesting that restraining TEC migration by Clu may be required for the renal repair and regeneration after injury.
DISCUSSION
Clu has been previously characterized as a chaperone-like protein; it contains many amphiphilic helices, binds to other proteins to form soluble complexes (10, 53) , and functions in both the extracellular and intracellular compartments of the cell (14, 38) . Although it was discovered Ͼ30 years ago (20) , and an immense volume of research has been dedicated to it since, the biological activities of this protein are still not fully understood. In the kidney, upregulation of Clu expression in renal tubules has been reported in a variety of different renal pathologies, such as IRI (56), UUO (21) , aging nephropathy (25) , and nephrotoxic drug administration (9, 47) . Similarly, Clu has been reported to protect the kidney from aging-related glomerulopathy (40) , IRI (56) , and UUO-induced renal fibrosis (23) in murine models. This study demonstrates for the first time that the expression of Clu in renal tubules after IRI is needed for renal repair, regeneration, and renoprotection, which is associated with the promotion of tubular cell proliferation.
The kidney has a remarkable capacity to repair itself after injury, so an understanding of this process will potentially lead to the development of improved regenerative strategies addressing kidney injury (30) . In Clu null kidneys, after IRI renal tissue repair or regeneration is not seen at the beginning of 7 days (Fig. 2) , but occurs at day 14 (unpublished observations), while in WT controls, the repair starts at day 3 and reaches near completion at day 7 (Fig. 2) . These data suggest that Clu may be required for renal repair. Similar results have been observed in the regeneration of the pancreas after partial pancreatectomy, indicated by the finding that in Clu KO mice pancreatectomy results in a poor formation of regenerating lobule, particularly regenerating ␤ cells, while in WT mice the pancreatectomy is associated with a robust development of new lobules with ductules, acini, and endocrine islets (26) . How Clu mediates tissue regeneration, such as in the kidney after IRI, has not yet been seriously investigated.
It has been documented previously in the literature that renal repair is associated with a cascade of dedifferentiation, proliferation, and migration of the surviving epithelial cells, which may also include mesenchymal stem cells to replace dead cells after injury (4, 13, 19, 36) . During murine embryogenesis, Clu expression is widely found in developing epithelia, such as in the epithelial cells of comma-and S-shaped bodies of the primordial kidney (15) but may not be absolutely required for the differentiation and morphogenesis, as WT and Clu KO mice were not found to be phenotypically different in postnatal development (32) . Interestingly, one study shows that a quantitative estimation of large motor neuron populations in the facial nucleus reveals a significant deficit in motor cells (ϳ16%) in Clu KO compared with that in WT mice (6) , and Clu increases migration of cardiac progenitor cells by increasing CXCR4 expression (28) . These studies may imply that the absence of Clu expression in Clu KO kidneys may lead to a decrease in the number and migration of renal stem/progenitor cells that have been found to contribute to renal repair after injury (34, 39, 48) . However, ectopic expression of Clu in cultured TECs inhibits cell migration compared with that in mocktransfected cells (Fig. 8) , suggesting that this in vitro experimental system may not be the same as seen in Clu- expressing WT kidneys compared with Clu null kidneys, and/or Clu may regulate cell migration differently in different cell types, as in the promotion of stem/progenitor cell migration as reported previously (28) but inhibition of differentiated epithelial cell migration as shown in Fig. 8 .
During renal repair after injury, the upregulation of Clu expression is positively correlated with the levels of cell proliferation and tissue damage in the kidneys (Figs. 1, 2 , and 5) but is not seen in the proliferating tubular cells. The immunohistochemical staining of Clu is mainly seen in the distal-like tubules (Fig. 1) , whereas Ki67 expression is detected in the proximal tubules (Fig. 5) . Similarly, Witzgall et al. (52) have reported that in the kidney after IRI, proliferating cell nuclear antigen (PCNA) is detected primarily in the S3 segment of the proximal tubule, while Clu is also expressed primarily in the S3 segment and as well in the distal tubules. However, none of these cells with upregulated Clu are positively stained with PCNA, suggesting that proliferating TECs in the S3 segment of the proximal tubules do not express an upregulated level of Clu in an immunohistochemical staining assay. An increase in cell proliferation in Clu-expressing WT kidneys is consistent with enhanced cell growth in cultured TECs with ectopic expression of Clu (Fig. 6) . PCR array analysis indicates that compared with a Clu-negative background (Clu KO kidneys) Clu upregulates many cell cycle-related genes that are associated with renal regeneration in kidneys postinjury and cell proliferation in cultured TECs (Table 1) . However, the mechanisms by which Clu mediates renal repair and regeneration after injury are still not fully understood. In the kidney, Clu expression is localized to both dedifferentiated and dying epithelial cells (16) , suggesting that it may function in both surviving and dying epithelial cells. Indeed, evidence in the literature has shown that Clu has many cellular functions in different experimental systems; it mediates cell aggregation (3), cell survival or anti-apoptosis (50, 56) , cell proliferation (37, 45, 46) , proapoptosis by its nuclear isoform (nClu) (2) , and clearance of cellular debris into nonprofessional phagocytes (1) . Recently, it has been found to stimulate the expression of metalloproteinase-9 and tumor necrosis factor-␣ and chemotactic migration of macrophages (43, 44) . Renal repair is a complex process of many cellular and molecular interactions; after injury, some renal tubular cells die by apoptosis and necrosis, followed by the repair or regeneration of the damaged tubules by repopulation of remaining survival TECs through dedifferentiation and proliferation (4, 19) , while at the same time infiltrating macrophages are also required for the process of renal repair (55) . How the different functions of Clu combine to facilitate renal repair processes is not clear, but it can be rationally hypothesized that following tissue injury the upregulated Clu in dying cells may promote the clearance of cellular debris into both nonprofessional and professional (macrophage) phagocytes; colony stimulating factor-1, secreted from activated macrophages or others, stimulates the proliferation of dedifferentiated TECs (33), while Clu in dedifferentiated TECs enhances cell survival in the inflammatory microenvironment and cell proliferation and differentiation by upregulating expression of many cell cyclerelated genes. Indeed, Clu has been reported to enhance neuronal survival and differentiation from human neural precursor cells in cultures (8) , and the proliferation of corneal epithelial cells by the induction of hepatocyte growth factor (37) and of astrocytes by epidermal growth factor (45).
In conclusion, Clu is a multifunctional protein constitutively expressing in the kidney, and its expression is induced in many types of renal pathologies, including AKI. Using Clu KO vs. WT mice, it has been demonstrated that Clu expression increases the resistance of the kidney to IRI (56), aging-related glomerulopathy (40) , and renal fibrosis in obstructive nephropathy (23) , and the present study further extends these findings in demonstrating a role for Clu in renal repair after IRI. The mechanisms by which Clu exerts its effects require further investigation; however, benefits of these insights may translate into wide-ranging therapies for the prevention or accelerated repair of renal units post-acute injury or kidney disease.
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